In addition, COSCIENS is progressing with the Phase 2a clinical efficacy study for its avenanthramide-based product, following a successful Phase 1 trial. The study is being conducted at the ...

Medically reviewed by Aviv Joshua, MS, RDN While blueberries are known for their antioxidants, many other foods like dark ...

results from our avenanthramide product and other products under development may not be successful or may not support advancing the product; the failure of the DETECT-trial to achieve its primary ...

The company also announced the initiation of a Phase 2a clinical study for its avenanthramide-based product, following a successful Phase 1 trial. In leadership developments, COSCIENS appointed Anna ...

Detailed price information for Cosciens Biopharma Inc (CSCI-Q) from The Globe and Mail including charting and trades.

In addition, COSCIENS is progressing with the Phase 2a clinical efficacy study for its avenanthramide-based product, following a successful Phase 1 trial. The study is being conducted at the Montreal ...